Acquired haemophilia in the elderly is a severe disease: Report of five new cases

Haemophilia

Volumn 7, Issue 4, 2001, Pages 428-432

  Godreuil, S ^a   Navarro, R ^a   Quittet, P ^a   Landreau, L ^a   Schved, J F ^a   Biron Andreani C ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Acquired haemophilia; Clinical experience; Elderly; FVIII inhibitors; Recombinant factor VIIa

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

AGED; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELDERLY CARE; FEMALE; GOODPASTURE SYNDROME; HEMOPHILIA; HUMAN; KIDNEY SURGERY; KIDNEY TUMOR; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; MALE;

EID: 0034920338     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2001.00531.x     Document Type: Article

References (28)

1. A survey of 215 non-haemophiliac patients with inhibitors to factor VIII
2. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period
3. Use of porcine factor VIII in the treatment of patients with acquired haemophilia
4. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicentre study
5. Acquired haemophilia: An important but often unrecognised cause of bleeding in elderly people
6. Acquired haemophilia in the elderly
7. Post-partum factor VIII inhibitors
8. Acquired haemophilia: Experience of two centres with 17 new cases
9. Acquired haemophilia - A study of ten cases
10. Simultaneous occurrence of lupus anticoagulant, factor VIII inhibitor and localized pemphigoid
11. Acquired haemophilia: A natural history study of 16 patients with FVIII inhibitors receiving little or no therapy
12. Laboratory tests or factor VIII inhibitors, their variation, significance and interpretation
13. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada
14. Acquired haemophilia
15. Hemarthrosis in patients with acquired factor VIII inhibitor
16. Solid tumor and factor VIII antibodies
17. Acquired inhibitors in malignant and nonmalignant disease states
18. Acquired factor VIII inhibitor associated with a prostatic cancer: Simultaneous occurrence and healing
19. Factor VIII inhibitor and bronchogenic carcinoma
20. Cancer
21. Clinical expression of auto-immune diseases in older adults
22. Acquired haemophilia and its management
23. Efficacy of prothrombin complex concentrates in haemophiliacs with antibodies to factor VIII. A multicenter therapeutic trial
24. Use of prothrombin complex concentrates in the management of bleeding in haemophiliacs with inhibitors benefits and limitations
25. Overall experience with NovoSeven
26. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoanti-bodies
27. A more uniform measurement of factor VIII inhibitors
28. Inter-laboratory variability of the measurement of low titre Factor VIII:C inhibitor in haemophiliacs: Improvement by the Nijmegen modification of the Bethesda assay and the use of common lyophilized plasmas